The overall goal of our laboratory is to understand the genetic and metabolic defects that produce hypercholesterolemia and atherosclerosis in man. We have defined a new pathway for the control of cholesterol metabolism in human cells. This pathway, called the low-density lipoprotein (LDL) pathway, consists of an ordered sequence of events by which cells bind LDL at a high affinity surface receptor site, internalize the lipoprotein by endocytosis, and release the lipoprotein cholesterol for use in cellular membrane synthesis. The importance of the LDL pathway is illustrated by the demonstration that mutations at two different steps in this sequence produce three important clinical disorders involving hypercholesterolemia and/or atherosclerosis in man. Since submission of the parent grant (HL-20948), we have made a major breakthrough that allows us to probe the genetics of the LDL receptor pathway in a powerful way. We have divised a method to extract the cholesteryl esters from the core of LDL and to reconstitute this core with a variety of oxogenous lipids. The reconstituted LDL retains the ability to bind to the LDL receptor of cultured cells, thereby delivering its contained lipid only to cells that possess LDL receptors. We now propose to synthesize toxic molecules that can be incorporated into LDL. Use of such reconstituted toxic LDL will permit the isolation of mutant clones of cultured cells that have blocks at specific sites in the LDL receptor pathway. A biochemical comparison of the molecular properties of such mutant clones with those of normal cells should allow the identification of hitherto unknown molecules that participate in the receptor-mediated uptake of LDL. The availability of cells with experimentally-induced mutations with blocks in the LDL pathway will make feasible a type of definitive biochemical analysis that would otherwise not be possible.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL020948-09
Application #
3097768
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1977-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Overall Medical
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
DeBose-Boyd, Russell A; Ye, Jin (2018) SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond. Trends Biochem Sci 43:358-368
Brown, Michael S; Radhakrishnan, Arun; Goldstein, Joseph L (2018) Retrospective on Cholesterol Homeostasis: The Central Role of Scap. Annu Rev Biochem 87:783-807
Russell, David W (2018) Lucky, times ten: A career in Texas science. J Biol Chem 293:18804-18827
Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306
Stender, Stefan; Smagris, Eriks; Lauridsen, Bo K et al. (2018) Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride. Hepatology 67:2182-2195
Schumacher, Marc M; Jun, Dong-Jae; Johnson, Brittany M et al. (2018) UbiA prenyltransferase domain-containing protein-1 modulates HMG-CoA reductase degradation to coordinate synthesis of sterol and nonsterol isoprenoids. J Biol Chem 293:312-323
Mitsche, Matthew A; Hobbs, Helen H; Cohen, Jonathan C (2018) Patatin-like phospholipase domain-containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. J Biol Chem 293:6958-6968
Banfi, Serena; Gusarova, Viktoria; Gromada, Jesper et al. (2018) Increased thermogenesis by a noncanonical pathway in ANGPTL3/8-deficient mice. Proc Natl Acad Sci U S A 115:E1249-E1258
Fine, Michael; Schmiege, Philip; Li, Xiaochun (2018) Structural basis for PtdInsP2-mediated human TRPML1 regulation. Nat Commun 9:4192
Linden, Albert G; Li, Shili; Choi, Hwa Y et al. (2018) Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J Lipid Res 59:475-487

Showing the most recent 10 out of 766 publications